{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:57:55Z","timestamp":1792511875622,"version":"4.5.0"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2011,3,12]],"date-time":"2011-03-12T00:00:00Z","timestamp":1299888000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1007\/s00415-011-5990-4","type":"journal-article","created":{"date-parts":[[2011,3,11]],"date-time":"2011-03-11T14:35:28Z","timestamp":1299854128000},"page":"1729-1731","source":"Crossref","is-referenced-by-count":28,"title":["Ifosfamide associated myoclonus-encephalopathy syndrome"],"prefix":"10.1007","volume":"258","author":[{"given":"Rodolfo","family":"Savica","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro A.","family":"Rabinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith A.","family":"Josephs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,3,12]]},"reference":[{"issue":"Suppl 2","key":"5990_CR1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000073351","volume":"65","author":"J Klastersky","year":"2003","unstructured":"Klastersky J (2003) Side effects of ifosfamide. Oncology 65(Suppl 2):7\u201310","journal-title":"Oncology"},{"issue":"11","key":"5990_CR2","doi-asserted-by":"crossref","first-page":"967","DOI":"10.2165\/00002512-200724110-00008","volume":"24","author":"A Brunello","year":"2007","unstructured":"Brunello A, Basso U, Rossi E, Stefani M, Ghiotto C, Marino D et al (2007) Ifosfamide-related encephalopathy in elderly patients : report of five cases and review of the literature. Drugs Aging 24(11):967\u2013973","journal-title":"Drugs Aging"},{"issue":"2","key":"5990_CR3","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.clon.2006.11.003","volume":"19","author":"T Ajithkumar","year":"2007","unstructured":"Ajithkumar T, Parkinson C, Shamshad F, Murray P (2007) Ifosfamide encephalopathy. Clin Oncol (R Coll Radiol) 19(2):108\u2013114","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"4","key":"5990_CR4","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/pbc.22361","volume":"54","author":"B Ames","year":"2010","unstructured":"Ames B, Lewis LD, Chaffee S, Kim J, Morse R (2010) Ifosfamide-induced encephalopathy and movement disorder. Pediatr Blood Cancer 54(4):624\u2013626","journal-title":"Pediatr Blood Cancer"},{"issue":"5\u20136","key":"5990_CR5","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.neucli.2006.12.003","volume":"36","author":"C Brefel-Courbon","year":"2006","unstructured":"Brefel-Courbon C, Gardette V, Ory F, Montastruc JL (2006) Drug-induced myoclonus: a French pharmacovigilance database study. Neurophysiol Clin 36(5\u20136):333\u2013336","journal-title":"Neurophysiol Clin"},{"key":"5990_CR6","volume-title":"Involuntary Movements","author":"S Fahn","year":"2010","unstructured":"Fahn S (2010) Involuntary Movements, 12th edn. Williams and Wilkins, Lippincott","edition":"12"},{"issue":"2","key":"5990_CR7","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1345\/aph.1G114","volume":"40","author":"PN Patel","year":"2006","unstructured":"Patel PN (2006) Methylene blue for management of Ifosfamide-induced encephalopathy. Ann Pharmacother 40(2):299\u2013303","journal-title":"Ann Pharmacother"},{"issue":"4","key":"5990_CR8","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s002280050102","volume":"50","author":"A Kupfer","year":"1996","unstructured":"Kupfer A, Aeschlimann C, Cerny T (1996) Methylene blue and the neurotoxic mechanisms of ifosfamide encephalopathy. Eur J Clin Pharmacol 50(4):249\u2013252","journal-title":"Eur J Clin Pharmacol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-011-5990-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-011-5990-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-011-5990-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T07:41:07Z","timestamp":1637394067000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-011-5990-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,12]]},"references-count":8,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["5990"],"URL":"https:\/\/doi.org\/10.1007\/s00415-011-5990-4","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,12]]}}}